奇士達(06918.HK)擬折讓約19.4%配售最多1.25億股 淨籌1610萬港元
格隆匯8月6日丨奇士達(06918.HK)公吿,於2025年8月6日,配售代理與公司訂立配售協議,據此,公司有條件同意透過配售代理,按盡力原則,以每股配售股份0.133港元的配售價,向不少於六名承配人(其本身及其最終實益擁有人(如有)為獨立第三方)配售最多124,912,800股配售股份。配售股份將根據一般授權配發及發行。
每股配售股份0.133港元配售價較股份於配售協議日期在聯交所所報收市價每股0.165港元折讓約19.4%;預期配售事項的最高所得款項總額及所得款項淨額將分別為約1660萬港元及約1610萬港元。假設所有配售股份成功配售,每股配售股份的淨價將約為0.1292港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.